8-K - Monte Rosa Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 8, 2026, Monte Rosa Therapeutics, Inc. (the “Company”) entered into an Underwriting Agreement (the “Under

Material Agreement

$24.00$24.00$281.6M

9.01

. Financial Statements and Exhibits (d) Exhibits 1.1 Underwriting Agreement, dated January 8, 2026, by and between Monte Rosa Therapeutics, Inc., Jefferies LLC,

Exhibits Only

Source Document

Exhibits (5)

1.1

EX-1.1

4.1

EX-4.1

5.1

EX-5.1

8-K

99.1

EX-99.1